CollPlant Biotechnologies Ltd Cost Of Sales
CollPlant Biotechnologies Ltd (CLGN) reported Cost Of Sales of $1.88 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-01.
Discontinued › Expense Statement
ifrs-full:CostOfSales · last filed 2020-04-01
- CollPlant Biotechnologies Ltd cost of sales for the quarter ending 2018-06-30 was 238.00K ILS.
ILS
| Period end | Cost Of Sales 3 month | Cost Of Sales 6 month | Cost Of Sales 12 month |
|---|---|---|---|
| 2018-12-31 | 1.43M ILS 20-F · filed 2019-04-01 | ||
| 2018-06-30 | 238.00K ILS 6-K · filed 2018-09-21 | 324.00K ILS 6-K · filed 2018-09-21 | |
| 2017-12-31 | 52.00K ILS 20-F · filed 2019-04-01 |
USD
| Period end | Cost Of Sales 3 month | Cost Of Sales 3 month as first filed | Cost Of Sales 6 month | Cost Of Sales 6 month as first filed | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-12-31 | $1.88M 20-F · filed 2020-04-01 | |||||
| 2019-06-30 | $453.00K 6-K · filed 2019-09-26 | $858.00K 6-K · filed 2019-09-26 | ||||
| 2018-12-31 | $1.66M 20-F · filed 2020-04-01 | $380.00K 20-F · filed 2019-04-01 | ||||
| 2018-06-30 | $67.00K 6-K · filed 2019-09-26 | $65.00K 6-K · filed 2018-09-21 | $92.00K 6-K · filed 2019-09-26 | $89.00K 6-K · filed 2018-09-21 | ||
| 2017-12-31 | $48.00K 20-F · filed 2020-04-01 | $15.00K 20-F · filed 2018-03-20 |